DIEMX
Price
$59.27
Change
-$0.30 (-0.50%)
Updated
Sep 11 closing price
Net Assets
4.91B
RNWHX
Price
$107.05
Change
-$0.71 (-0.66%)
Updated
Sep 11 closing price
Net Assets
90.01B
Interact to see
Advertisement

DIEMX vs RNWHX

DIEMX vs RNWHX Comparison Chart in %
View a ticker or compare two or three
VS
DIEMX vs. RNWHX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DIEMX is a StrongBuy and RNWHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 90B vs. DIEMX (4.91B). DIEMX pays higher dividends than RNWHX: DIEMX (1.55) vs RNWHX (1.15). DIEMX was incepted earlier than RNWHX: DIEMX (9 years) vs RNWHX (11 years). DIEMX (0.91) is less costly to investors than RNWHX (0.72). DIEMX is a more actively managed with annual turnover of: 137.00 vs. RNWHX (46.00). RNWHX has a lower initial minimum investment than DIEMX: RNWHX (250) vs DIEMX (500000). DIEMX annual gain was more profitable for investors over the last year : 32.91 vs. RNWHX (17.19). DIEMX return over 5 years is better than : 21.62 vs. RNWHX (17.68).
DIEMXRNWHXDIEMX / RNWHX
Total Expense Ratio0.910.72126%
Annual Report Gross Expense Ratio0.910.72126%
Fund Existence9 years11 years-
Gain YTD24.03916.447146%
Front LoadN/AN/A-
Min. Initial Investment500000250200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.91B90B5%
Annual Yield % from dividends1.551.15135%
Returns for 1 year32.9117.19191%
Returns for 3 years84.1853.84156%
Returns for 5 years21.6217.68122%
Returns for 10 yearsN/A111.44-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLPEX46.310.28
+0.61%
Fidelity Advisor Low-Priced Stock C
FACDX64.25N/A
N/A
Fidelity Advisor Health Care A
EXHAX26.61N/A
N/A
Manning & Napier Pro-Blend Max Term S
LMCFX35.98N/A
N/A
Lord Abbett Mid Cap Stock F
MSAWX22.51N/A
N/A
Morgan Stanley Inst Asia Opp C